Company
PT Industri Jamu dan Farmasi Sido Muncul Tbk
Headquarters: Semarang, Indonesia
Employees: 2,971
Market Cap
Rp22.350 Trillion
IDR as of July 1, 2024
US$1.36 Billion
PT Industri Jamu dan Farmasi Sido Muncul Tbk Categories
Indonesia Healthcare Drug Manufacturers—Specialty & GenericIndonesia Healthcare Indonesia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverages related to health in Indonesia and internationally. The company produces various medicines consisting of ethical products, OTC products, food supplements, and medical herbs. Its products include Anacetine, a medicine to reduce fever; Berlosid, a medicine for gastric pains; Anabion, a multivitamin for children; Suprabion, a multivitamins for adults; and Telon Oil. The company also manufactures herbal extracts, as well as offers confectionary products, energy and health drinks, and other products. In addition, it is involved in commerce and land transportation activities. The company was founded in 1940 and is headquartered in Semarang, Indonesia. PT Industri Jamu dan Farmasi Sido Muncul Tbk operates as a subsidiary of PT Hotel Candi Baru.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
PT Industri Jamu dan Farmasi Sido Muncul Tbk has the following listings and related stock indices.
Stock: IDX: SIDO wb_incandescent